709 related articles for article (PubMed ID: 22108197)
1. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease.
Bodd M; Kim CY; Lundin KE; Sollid LM
Gastroenterology; 2012 Mar; 142(3):552-61. PubMed ID: 22108197
[TBL] [Abstract][Full Text] [Related]
2. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
[TBL] [Abstract][Full Text] [Related]
3. Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires.
Bergseng E; Dørum S; Arntzen MØ; Nielsen M; Nygård S; Buus S; de Souza GA; Sollid LM
Immunogenetics; 2015 Feb; 67(2):73-84. PubMed ID: 25502872
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule.
Kapoerchan VV; Wiesner M; Hillaert U; Drijfhout JW; Overhand M; Alard P; van der Marel GA; Overkleeft HS; Koning F
Mol Immunol; 2010 Feb; 47(5):1091-7. PubMed ID: 19962195
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the binding of gluten T-cell epitopes to various human leukocyte antigen class II molecules.
Bergseng E; Sidney J; Sette A; Sollid LM
Hum Immunol; 2008 Feb; 69(2):94-100. PubMed ID: 18361933
[TBL] [Abstract][Full Text] [Related]
6. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses.
Vader W; Stepniak D; Kooy Y; Mearin L; Thompson A; van Rood JJ; Spaenij L; Koning F
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12390-5. PubMed ID: 14530392
[TBL] [Abstract][Full Text] [Related]
7. Modelling of HLA-DQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease.
Costantini S; Rossi M; Colonna G; Facchiano AM
J Mol Graph Model; 2005 Apr; 23(5):419-31. PubMed ID: 15781184
[TBL] [Abstract][Full Text] [Related]
8. Equilibrium and kinetic analysis of the unusual binding behavior of a highly immunogenic gluten peptide to HLA-DQ2.
Xia J; Sollid LM; Khosla C
Biochemistry; 2005 Mar; 44(11):4442-9. PubMed ID: 15766274
[TBL] [Abstract][Full Text] [Related]
9. Evidence that HLA-DQ9 confers risk to celiac disease by presence of DQ9-restricted gluten-specific T cells.
Bodd M; Tollefsen S; Bergseng E; Lundin KE; Sollid LM
Hum Immunol; 2012 Apr; 73(4):376-81. PubMed ID: 22342873
[TBL] [Abstract][Full Text] [Related]
10. HLA-DQ molecules as affinity matrix for identification of gluten T cell epitopes.
Dørum S; Bodd M; Fallang LE; Bergseng E; Christophersen A; Johannesen MK; Qiao SW; Stamnaes J; de Souza GA; Sollid LM
J Immunol; 2014 Nov; 193(9):4497-506. PubMed ID: 25261484
[TBL] [Abstract][Full Text] [Related]
11. A molecular basis for the T cell response in HLA-DQ2.2 mediated celiac disease.
Ting YT; Dahal-Koirala S; Kim HSK; Qiao SW; Neumann RS; Lundin KEA; Petersen J; Reid HH; Sollid LM; Rossjohn J
Proc Natl Acad Sci U S A; 2020 Feb; 117(6):3063-3073. PubMed ID: 31974305
[TBL] [Abstract][Full Text] [Related]
12. Healthy HLA-DQ2.5+ Subjects Lack Regulatory and Memory T Cells Specific for Immunodominant Gluten Epitopes of Celiac Disease.
Christophersen A; Risnes LF; Bergseng E; Lundin KE; Sollid LM; Qiao SW
J Immunol; 2016 Mar; 196(6):2819-26. PubMed ID: 26895834
[TBL] [Abstract][Full Text] [Related]
13. Posttranslational modification of gluten shapes TCR usage in celiac disease.
Qiao SW; Ráki M; Gunnarsen KS; Løset GÅ; Lundin KE; Sandlie I; Sollid LM
J Immunol; 2011 Sep; 187(6):3064-71. PubMed ID: 21849672
[TBL] [Abstract][Full Text] [Related]
14. Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation.
Fallang LE; Bergseng E; Hotta K; Berg-Larsen A; Kim CY; Sollid LM
Nat Immunol; 2009 Oct; 10(10):1096-101. PubMed ID: 19718029
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis of celiac disease.
Koning F
J Mol Recognit; 2003; 16(5):333-6. PubMed ID: 14523946
[TBL] [Abstract][Full Text] [Related]
16. HLA-DQ2.5 genes associated with celiac disease risk are preferentially expressed with respect to non-predisposing HLA genes: Implication for anti-gluten T cell response.
Pisapia L; Camarca A; Picascia S; Bassi V; Barba P; Del Pozzo G; Gianfrani C
J Autoimmun; 2016 Jun; 70():63-72. PubMed ID: 27083396
[TBL] [Abstract][Full Text] [Related]
17. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes.
Moustakas AK; van de Wal Y; Routsias J; Kooy YM; van Veelen P; Drijfhout JW; Koning F; Papadopoulos GK
Int Immunol; 2000 Aug; 12(8):1157-66. PubMed ID: 10917890
[TBL] [Abstract][Full Text] [Related]
18. Two novel HLA-DQ2.5-restricted gluten T cell epitopes in the DQ2.5-glia-γ4 epitope family.
Qiao SW; Sollid LM
Immunogenetics; 2019 Nov; 71(10):665-667. PubMed ID: 31673720
[TBL] [Abstract][Full Text] [Related]
19. Assessing possible celiac disease by an HLA-DQ2-gliadin Tetramer Test.
Brottveit M; Ráki M; Bergseng E; Fallang LE; Simonsen B; Løvik A; Larsen S; Løberg EM; Jahnsen FL; Sollid LM; Lundin KE
Am J Gastroenterol; 2011 Jul; 106(7):1318-24. PubMed ID: 21364548
[TBL] [Abstract][Full Text] [Related]
20. A bispecific antibody targeting HLA-DQ2.5-gluten peptides potently blocks gluten-specific T cells induced by gluten ingestion in patients with celiac disease.
Hardy MY; Henneken LM; Russell AK; Okura Y; Mizoroki A; Ozono Y; Kobayashi S; Murakami Y; Tye-Din JA
Clin Immunol; 2024 Jul; 264():110259. PubMed ID: 38768856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
